Autifony Therapeutics Ltd.. (8/26/20). "Press Release: Autifony Therapeutics Regains Rights to Clinical Stage Kv3 Programme". Stevenage. |
2020-08-26 |
Freenome, Inc.. (8/26/20). "Press Release: Freenome Closes $270 Million Series C Financing to Advance Novel Multiomics Blood Testing Platform for Early Cancer Detection". South San Francisco, CA. |
2020-08-26 |
Cytosurge AG. (8/26/20). "Press Release: Cytosurge Announces Appointment of Thomas Bachmann to Board of Directors". Zurich. |
2020-08-26 |
Eppendorf AG. (8/25/20). "Press Release: Eppendorf AG Records Strong First Half-year 2020. Consolidated Revenue Grows by 6.6% to €403.7 Million in the First Six Months
> Consolidated revenue grows by 6.6% to €403.7 million in the first six months". Hamb |
2020-08-25 |
Bayer AG. (8/24/20). "Press Release: Bayer and Informed Data Systems Inc. (One Drop) Join Forces to Jointly Develop Digital Health Products across Therapeutic Areas". Berlin. |
2020-08-24 |
Bruker Corporation. (8/24/20). "Press Release: Bruker and Purity-IQ Sign Partnership Agreement to Transform the Cannabis Regulatory Landscape". Billerica, MA. |
2020-08-24 |
Moderna, Inc.. (8/24/20). "Press Release: Moderna Confirms Advanced Discussions with European Commission to Supply Europe with 80 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)". Cambridge, MA. |
2020-08-24 |
Qiagen N.V.. (8/21/20). "Press Release: Qiagen Announces New Chairman of Supervisory Board". Venlo. |
2020-08-21 |
Singleron Biotechnologies. (8/21/20). "Press Release: Berry Genomics and Singleron Biotechnologies Moved into Strategic Slliance". |
2020-08-21 |
Scienion AG. (8/19/20). "Press Release: Cellink Has Entered into an Agreement to Acquire Precision Dispensing Company Scienion AG". |
2020-08-19 |
Kronos Bio, Inc.. (8/19/20). "Press Release: Kronos Bio Appoints Dr. Yasir Al-Wakeel as Chief Financial Officer and Head of Corporate Development". San Mateo, CA & Cambridge, MA. |
2020-08-19 |
CureVac B.V.. (8/18/20). "Press Release: CureVac Announces Closing of Initial Public Offering". Tübingen & Boston, MA. |
2020-08-18 |
Evotec SE. (8/18/20). "Press Release: Evotec and Novo Nordisk Form Strategic Alliance to Develop Novel Therapies for Kidney Diseases". Hamburg. |
2020-08-18 |
Qiagen N.V.. (8/18/20). "Press Release: Qiagen Expands Integrated Coronavirus NGS and Software Solutions to Accelerate COVID-19 Research". Hilden & Germantown, MD. |
2020-08-18 |
Bayer AG. (8/18/20). "Press Release: Bayer Names Sara Boettiger as Head of Global Public Affairs, Science and Sustainability for Crop Science Division". Monheim. |
2020-08-18 |
Exscientia Ltd.. (8/18/20). "Press Release: Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats". Brussels. |
2020-08-18 |
Hua Medicine (Shanghai) Ltd.. (8/17/20). "Press Release: Bayer and Hua Medicine Announce Commercialization Agreement and Strategic Partnership for Investigational First-in-Class Novel Diabetes Treatment Dorzagliatin in China". Beijing & Shanghai. |
2020-08-17 |
Merck KGaA. (8/17/20). "Press Release: Merck Appoints Liz Henderson as New Regional Vice President, Merck Biopharma APAC". Singapore. |
2020-08-17 |
Seres Therapeutics, Inc.. (8/17/20). "Press Release: Seres Therapeutics, Inc. Announces Closing of Public Offerings of 12,075,000 Shares of Common Stock". Cambridge, MA. |
2020-08-17 |
CureVac B.V.. (8/14/20). "Press Release: CureVac Announces Pricing of Initial Public Offering". Tübingen & Boston, MA. |
2020-08-14 |
Qiagen N.V.. (8/13/20). "Press Release: Qiagen to Continue Successful Growth Strategy Focused on Execution and Greater Value Creation after Voluntary Public Takeover Offer Falls Short". Venlo. |
2020-08-13 |
Novo Holdings A/S. (8/12/20). "Press Release: Novo Ventures Portfolio Company F2G Closes US$60.8 Million Financing". Copenhagen. |
2020-08-12 |
Atriva Therapeutics GmbH. (8/11/20). "Press Release: Atriva Announces Closing of € 8.6 Million ($ 10.2 Million) Oversubscribed Convertible Loan". Tübingen. |
2020-08-11 |
Bayer AG. (8/11/20). "Press Release: Bayer to Acquire UK-based Biotech Kandy Therapeutics Ltd. [Not intended for U.S. and UK Media]". Berlin. |
2020-08-11 |
CureVac B.V.. (8/10/20). "Press Release: CureVac Announces Proposed Initial Public Offering of Common Shares". Tübingen. |
2020-08-10 |
Inveox GmbH. (8/10/20). "Press Release: Roche Diagnostics Germany and Inveox Jointly Drive Digital Solutions in Histopathology". Mannheim & Garching. |
2020-08-10 |
NBE Therapeutics AG. (8/10/20). "Press Release: NBE-Therapeutics Appoints Erich Schlick as Chairman of the Board of Directors". Basel. |
2020-08-10 |
Immunic, Inc.. (8/10/20). "Press Release: Immunic, Inc. Announces Closing of $103.5 Million Public Offering, including Full Exercise of Underwriters’ Option to Purchase Additional Shares". New York, NY. |
2020-08-10 |
Bruker Corporation. (8/7/20). "Press Release: Utrecht University and Bruker Announce Collaboration to Develop Methods for Studying Protein Structures and Interactions by Mass Spectrometry". Billerica, MA. |
2020-08-07 |
T-Knife GmbH. (8/6/20). "Press Release: T-Knife Completes € 66 Million Series A Financing to Develop Next-Generation T-Cell Therapies". Berlin. |
2020-08-06 |
Merck KGaA. (8/6/20). "Press Release: Leadership Change within Group Communications at Merck". Darmstadt. |
2020-08-06 |
Evotec SE. (8/5/20). "Press Release: Evotec and Secarna Pharmaceuticals Form Strategic Partnership in the Field of Antisense Therapy". Hamburg & Marburg. |
2020-08-05 |
Immunic, Inc.. (8/5/20). "Press Release: Immunic, Inc. Announces Pricing of $90.0 Million Public Offering of Common Stock". New York, NY. |
2020-08-05 |
Affimed N.V.. (8/5/20). "Press Release: Affimed Announces Two New Appointments to Its Supervisory Board". Heidelberg. |
2020-08-05 |
AC Immune S.A.. (8/5/20). "Press Release: AC Immune Reports Q2 2020 Financial Results and Provides Business Update". Lausanne. |
2020-08-05 |
Versant Ventures. (8/5/20). "Press Release: Versant Ventures Launches Matterhorn Biosciences". Basel. |
2020-08-05 |
GentiBio, Inc.. (8/5/20). "Press Release: GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Infl |
2020-08-05 |
CureVac AG. (8/4/20). "Press Release: CureVac Appoints Dr. Franz-Werner Haas as Chief Executive Officer and Dr. Igor Splawski as Chief Scientific Officer". Tübingen. |
2020-08-04 |
Spindiag GmbH. (8/4/20). "Press Release: Spindiag Appoints Winston Griffin as Chief Financial Officer to Support its Global Finance and Market Expansion Strategy". Freiburg/Breisgau. |
2020-08-04 |
Thermo Fisher Scientific Inc.. (8/4/20). "Press Release: Thermo Fisher Scientific Confirms Offer to Acquire Qiagen Shares Expires on August 10". Waltham, MA. |
2020-08-04 |
MYR GmbH. (8/4/20). "Press Release: MYR Pharmaceuticals Receives Conditional Marketing Authorization by the European Commission for Hepcludex". Bad Homburg. |
2020-08-04 |
Valo Therapeutics Ltd.. (8/3/20). "Press Release: Valo Therapeutics Appoints Industry Veteran Paul G Higham as CEO". Oxford & Helsinki. |
2020-08-03 |
NBE Therapeutics AG. (8/3/20). "Press Release: NBE-Therapeutics Appoints Bertrand Damour as Chief Executive Officer". Basel. |
2020-08-03 |
Immunic, Inc.. (8/2/20). "Press Release: Immunic, Inc. Reports Positive Top-line Data from Phase 2 EMPhASIS Trial of IMU-838 in Patients with Relapsing-Remitting Multiple Sclerosis – Reports Results 2020 Q2". New York, NY. |
2020-08-02 |
Siemens Healthineers AG. (8/2/20). "Press Release: Siemens Healthineers Plans Acquisition of Varian". |
2020-08-02 |
MorphoSys AG. (8/1/20). "Press Release: FDA Approves Monjuvi (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)". Planegg & Wilmington, DE. |
2020-08-01 |
PharmaLex GmbH. (8/1/20). "Press Release: PharmaLex Strengthens Its Commercial Organization". Frankfurt. |
2020-08-01 |
BaselArea.swiss. (7/31/20). "Press Release: Yokogawa Establishes Innovation Center in Allschwil". |
2020-07-31 |
BioNTech SE. (7/31/20). "Press Release: BioNTech Announces Strategic Collaboration with Regeneron to Advance FixVac and Libtayo (cemiplimab) Combination in Melanoma". Mainz. |
2020-07-31 |
BioNTech SE. (7/31/20). "Press Release: Pfizer and BioNTech to Supply Japan with 120 Million Doses of Their BNT162 mRNA-Based Vaccine Candidate". New York, NY & Mainz. |
2020-07-31 |
Proxygen GmbH. (7/31/20). "Press Release: Boehringer Ingelheim Awards Proxygen with BI Innovation Prize". Vienna. |
2020-07-31 |
Genespire S.r.l.. (7/30/20). "Press Release: Genespire Appoints Jörn Aldag as Chairman of the Board of Directors". Milan. |
2020-07-30 |
Vico Therapeutics B.V.. (7/29/20). "Press Release: Biotech Vico Therapeutics Raises $31 Million (€27 Million) in Series A Financing Round to Advance Therapies for Rare Central Nervous System Diseases". Leiden. |
2020-07-29 |
Alentis Therapeutics AG. (7/29/20). "Press Release: Alentis Therapeutics Names Roberto Iacone CEO". Basel. |
2020-07-29 |
DNA Script. (7/29/20). "Press Release: DNA Script Expands Series B to $89M". Paris & South San Francisco, CA. |
2020-07-29 |
Wacker Chemie AG. (7/28/20). "Press Release: Wacker Invests in Amsterdam Biotech Site". Munich & Amsterdam. |
2020-07-28 |
Polyphor Ltd.. (7/28/20). "Press Release: Polyphor Strengthens Financial Flexibility with CHF 19.3 million Equity-linked Financing". Allschwil. |
2020-07-28 |
4basebio AG. (7/28/20). "Press Release: 4basebio Informs about Takeover Bid by Sparta AG". Heidelberg & Cambridge. |
2020-07-28 |
Coulter Partners. (7/28/20). "Press Release: Coulter Partners Secures Chief Executive Officer for Optimapharm". |
2020-07-28 |
BioNTech SE. (7/27/20). "Press Release: BioNTech Announces Closing of $512 Million Underwritten Offering of American Depositary Shares". Mainz. |
2020-07-27 |
BioNTech SE. (7/27/20). "Press Release: Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study". New York, NY & Mainz. |
2020-07-27 |
Biognosys AG. (7/23/20). "Press Release: Boehringer Ingelheim and Biognosys Join Forces on Applying Quantitative Proteomics Tools in Drug Discovery". Biberach & Schlieren. |
2020-07-23 |
Max Planck Institute for Biophysical Chemistry (MPI-BPI). (7/22/20). "Press Release: One of the World´s Three Most Powerful High-resolution 1.2 GHz NMR Spectrometers Comes to Göttingen". |
2020-07-22 |
Computomics GmbH. (7/22/20). "Press Release: Computomics Is Member of the German Aerospace Center Network Space2Agriculture". |
2020-07-22 |
Bayer AG. (7/22/20). "Press Release: Vesigen Therapeutics Launches with USD 28.5 Million Series A Investment Led by Leaps by Bayer and Morningside Ventures". Cambridge, MA & Berlin. |
2020-07-22 |
T3 Pharmaceuticals AG. (7/22/20). "Press Release: T3 Pharma Raises 25M CHF to Advance Bacterial Cancer Therapy through Clinic". Basel. |
2020-07-22 |
BioNTech SE. (7/22/20). "Press Release: Pfizer and BioNTech Announce an Agreement with U. S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2". New York, NY & Mainz. |
2020-07-22 |
BioNTech SE. (7/22/20). "Press Release: BioNTech Announces Pricing of Upsized Underwritten Offering and Terms of Rights Offering". Mainz. |
2020-07-22 |
Tubulis GmbH. (7/21/20). "Press Release: Tubulis Raises €10.7 M Series A to Advance Development of a New Generation of Antibody-Drug Conjugates". Munich. |
2020-07-21 |
Quantro Therapeutics GmbH. (7/21/20). "Press Release: Quantro Therapeutics Launched with Breakthrough Oncology Drug Discovery Platform". Vienna. |
2020-07-21 |
BioNTech SE. (7/21/20). "Press Release: Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data". Mainz & New York, NY. |
2020-07-21 |
BioNTech SE. (7/21/20). "Press Release: BioNTech Announces Proposed Public Offerings". Mainz. |
2020-07-21 |
CureVac AG. (7/21/20). "Press Release: CureVac Raises a Total of USD 640 Million in Private Financing Round". Tübingen. |
2020-07-21 |
Optimapharm d.d.. (7/21/20). "Press Release: Optimapharm Appoints Dr. Andrew Copestake as Chief Executive Officer". |
2020-07-21 |
Gain Therapeutics, Inc.. (7/21/20). "Press Release: Gain Therapeutics, Inc. Announces Close of $10 Million Series B Financing". Bethesda, MD. |
2020-07-21 |
Gemoab GmbH. (7/20/20). "Press Release: Gemoab and Intellia Therapeutics Enter into Research Collaboration and Licensing Agreement on Next-Generation Cellular Immunotherapy". Dresden. |
2020-07-20 |
BioNTech SE. (7/20/20). "Press Release: Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2". New York, NY & Mainz. |
2020-07-20 |
Valneva S.E.. (7/20/20). "Press Release: Valneva Confirms Participation in UK Government COVID-19 Vaccine Response Program". Saint-Herblain. |
2020-07-20 |
CureVac AG. (7/20/20). "Press Release: GSK and CureVac Announce Strategic mRNA Technology Collaboration". |
2020-07-20 |
Qiagen N.V.. (7/16/20). "Press Release: Thermo Fisher Scientific and Qiagen N.V. Agree on Amended Terms to Acquisition Agreement". Waltham, MA & Venlo. |
2020-07-16 |
Zur Rose Group AG. (7/16/20). "Press Release: Zur Rose Group Acquires TeleClinic, Germany's Leading Telemedicine Provider". |
2020-07-16 |
[iito] Business Intelligence. (7/15/20). "Press Release: [iito] Launches ADucation Campaign Summer 2020". Bremen. |
2020-07-15 |
Merck KGaA. (7/15/20). "Press Release: Merck Invests € 18 Million in New Life Science Laboratory in Switzerland". Darmstadt. |
2020-07-15 |
Waters Corporation. (7/15/20). "Press Release: Waters Corporation Names Udit Batra President and Chief Executive Officer. Announces Preliminary Second Quarter 2020 Sales". Milford, MA. |
2020-07-15 |
Versameb AG. (7/15/20). "Press Release: Versameb Raises CHF 6 Million and Strengthens Team to Advance Its VERSagile Technology Platform towards Clinical Trials". Basel. |
2020-07-15 |
Miltenyi Biotec B.V. & Co. KG. (7/14/20). "Press Release: Miltenyi Biotec Offers Automated and Closed Adherent Cell Culture Solutions on CliniMACS Prodigy". Bergisch Gladbach. |
2020-07-14 |
Roche. (7/14/20). "Press Release: Roche Collaborates with Blueprint Medicines to Bring a New Treatment to People with RET-altered Cancers". Basel. |
2020-07-14 |
iOnctura S.A.. (7/14/20). "Press Release: iOnctura Extends Series A to EUR 20.1m". Geneva. |
2020-07-14 |
MorphoSys AG. (7/14/20). "Press Release: MorphoSys' Licensee Janssen Announces Approval of Tremfya (Guselkumab) by U.S. FDA for Treatment of Adults with Active Psoriatic Arthritis". Planegg. |
2020-07-14 |
Illumina, Inc.. (7/14/20). "Press Release: Illumina Acquires Enancio’s Compression Software. Reduces Genomic Data Storage and Transfer Costs Associated with the Data Deluge". |
2020-07-14 |
BioNTech SE. (7/13/20). "Press Release: Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2". New York, NY & Mainz. |
2020-07-13 |
Merck KGaA. (7/13/20). "Press Release: Changes in Merck Executive Board. Belén Garijo appointed Vice Chairman of the Executive Board and Deputy CEO – Udit Batra Leaves". Darmstadt. |
2020-07-13 |
Merck KGaA. (7/10/20). "Press Release: Merck Opens its Largest M Lab Collaboration Center in Shanghai". Darmstadt. |
2020-07-10 |
Forbion Capital Partners. (7/9/20). "Press Release: Forbion Announces First Close of Forbion Growth Opportunities Fund at EUR 185 million (USD 208 million)". Naarden & Munich. |
2020-07-09 |
Anergis S.A.. (7/9/20). "Press Release: Anergis and Virometix Announce Research Collaboration to Use Synthetic Virus-Like Particles for Ultra-Fast Allergy Immunotherapy". Epalinges. |
2020-07-09 |
Novo Holdings A/S. (7/9/20). "Press Release: Major Danish Contribution to Billion-dollar Global Initiative to Combat Antimicrobial resistance". Copenhagen. |
2020-07-09 |
Moderna, Inc.. (7/9/20). "Press Release: Moderna and ROVI Announce Collaboration for OUS Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate". Cambridge, MA & Madrid. |
2020-07-09 |
MLM Medical Labs GmbH. (7/8/20). "Press Release: MLM Medical Labs Expands to the US and Nominates Thomas Wollman as Member of the Board". Düsseldorf. |
2020-07-08 |
VarmX B.V.. (7/8/20). "Press Release: VarmX Raises €32 million in Series B Financing to Develop Innovative Reversal Agent for the Treatment and Prevention of Severe Bleeding in Patients on Oral Anticoagulants". Leiden. |
2020-07-08 |
Kiadis Pharma N.V.. (7/8/20). "Press Release: Kiadis Licenses Previously Undisclosed Pre-clinical K-NK-cell Programs to Sanofi, with Total Potential Deal Value of €875 Million, plus Royalties". Amsterdam. |
2020-07-08 |